The Enterprise Value as of November 2024 (TTM) for Milestone Pharmaceuticals Inc. (MIST) is 139.34M

According to Milestone Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 139.34M. This represents a change of 11.79% compared to the average of 124.64M of the last 4 quarters.

Milestone Pharmaceuticals Inc. (MIST) Historical Enterprise Value (quarterly & annually)

How has MIST Enterprise Value performed in the past?

The mean historical Enterprise Value of Milestone Pharmaceuticals Inc. over the last ten years is 188.86M. The current 139.34M Enterprise Value has changed 7.28% with respect to the historical average. Over the past ten years (40 quarters), MIST's Enterprise Value was at its highest in in the March 2018 quarter at 390.38M. The Enterprise Value was at its lowest in in the March 2020 quarter at -56292250.32.

Milestone Pharmaceuticals Inc. (MIST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Milestone Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Milestone Pharmaceuticals Inc. (MIST) Average Enterprise Value

How has MIST Enterprise Value performed in the past?

The current Enterprise Value of Milestone Pharmaceuticals Inc. (MIST) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Milestone Pharmaceuticals Inc. (MIST) Enterprise Value vs. Peers

How is MIST’s Enterprise Value compared to its peers?

Milestone Pharmaceuticals Inc.’s Enterprise Value is less than DiaMedica Therapeutics Inc. (197.21M), less than Seres Therapeutics, Inc. (158.02M), less than Inhibikase Therapeutics, Inc. (154.45M), greater than Oncolytics Biotech Inc. (84.27M), greater than scPharmaceuticals Inc. (128.65M), greater than aTyr Pharma, Inc. (138.44M), greater than X4 Pharmaceuticals, Inc. (38.44M), greater than Galera Therapeutics, Inc. (-7482657.00), less than Terns Pharmaceuticals, Inc. (222.97M), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than HOOKIPA Pharma Inc. (-36166707.00), greater than Spero Therapeutics, Inc. (-8426888.00), greater than Bolt Biotherapeutics, Inc. (30.96M), less than Coherus BioSciences, Inc. (259.52M), less than Gracell Biotechnologies Inc. (5.61B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Monte Rosa Therapeutics, Inc. (439.72M), less than NewAmsterdam Pharma Company N.V. (1.37B), less than Inventiva S.A. (228.20M), less than Cullinan Oncology, Inc. (630.54M), less than Compass Therapeutics, Inc. (182.75M),

Build a custom stock screener for Milestone Pharmaceuticals Inc. (MIST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Milestone Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Milestone Pharmaceuticals Inc. (MIST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Milestone Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.